Watanabe, Ryota
Suehiro, Koichi
Mukai, Akira
Tanaka, Katsuaki
Yamada, Tokuhiro
Mori, Takashi
Nishikawa, Kiyonobu
Article History
Received: 26 December 2020
Accepted: 18 November 2021
First Online: 2 December 2021
Declarations
:
: This study was approved by the Ethics Committee of the Osaka City University Graduate School of Medicine on 23 February 2017 (reference number: 3693), and was performed in accordance with the Declaration of Helsinki. All participating subjects was informed about this study protocol in details and provided written informed consent before enrollment in this study.
: Not applicable.
: Dr. Suehiro has received speaker fees from Edwards Lifesciences and Otsuka Pharmaceutical Co. Ltd. Other authors have no conflicts of interest to declare.